SRS288 - Timing of re-resection following initial TURBT in high-risk non-muscle invasive bladder cancer: a retrospective review
British Journal of Surgery · 27.03.2026 · 113 (Supplement_2)
DOI: 10.1093/bjs/znag018.262 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Surgery, online erschienen am 27.03.2026. Verfasst von Amelia Simenacz und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction/Background Transurethral resection of bladder tumour (TURBT) is the standard first-line surgical treatment for bladder cancer. International guidelines from the European Association of Urology (EAU), American Urological Association (AUA), and NICE recommend re-resection within 2–6 weeks for high-risk non-muscle-invasive bladder cancer (NMIBC) or incomplete initial resections, to eliminate residual tumour and minimise understaging. Literature suggests that approximately 4.8% of tumours are upstaged at re-resection. This study aimed to assess adherence to these guidelines at a district general hospital.
Methods
A retrospective review of 122 operation notes and histology reports was conducted. Data collected included patient demographics, histopathology, and timing of multi-disciplinary team (MDT) discussions and re-resection procedures.
Results
Re-resection was indicated in 28.7% of cases. Only 8.6% of patients underwent re-resection within the recommended 6-week timeframe. The mean interval between initial TURBT and re-resection was 62.7 ± 26.9 days. The average time from TURBT to MDT discussion was 13.7 ± 10.5 days, and from MDT to re-resection was 49.0 ± 25.0 days. Tumour upgrading on histology was observed in 8.6% of re-resected cases. Among patients who required re-resection, 42.9% had initial operative findings suggestive of higher-grade disease.
Conclusions
Adherence to re-resection guidelines was low, highlighting a potential contributor to the higher rate of tumour upstaging observed compared to published data. Modifying the TURBT operative note template to prompt surgeons to request re-resection at the time of initial surgery, when high-grade features are identified may help improve conformity to guidelines.
Zitieren
APA
Simenacz, A., Antoniou, V., & Volanis, D. (2026). SRS288 - Timing of re-resection following initial TURBT in high-risk non-muscle invasive bladder cancer: a retrospective review. British Journal of Surgery, 113(Supplement_2). https://doi.org/10.1093/bjs/znag018.262
Vancouver
Simenacz A, Antoniou V, Volanis D. SRS288 - Timing of re-resection following initial TURBT in high-risk non-muscle invasive bladder cancer: a retrospective review. British Journal of Surgery. 2026;113(Supplement_2). doi:10.1093/bjs/znag018.262
BibTeX
@article{Simenacz2026,
author = {Simenacz, Amelia and Antoniou, Vaki and Volanis, Dimitrios},
title = {SRS288 - Timing of re-resection following initial TURBT in high-risk non-muscle invasive bladder cancer: a retrospective review},
journal = {British Journal of Surgery},
year = {2026},
volume = {113},
number = {Supplement_2},
doi = {10.1093/bjs/znag018.262}
}
EUVIMED